Abstract
Molecular testing has emerged as a valuable tool in the preoperative evaluation of cytologically indeterminate thyroid nodules. The addition of molecular testing to Bethesda III and IV thyroid FNAs has resulted in an overall decrease in diagnostic lobectomies/thyroidectomies. However, molecular testing is not indicated in all patients. This chapter highlights the clinical considerations when determining the appropriate usage of molecular testing in cytologically indeterminate thyroid nodules and currently available tests.
Original language | English (US) |
---|---|
Title of host publication | Controversies in Thyroid Nodules and Differentiated Thyroid Cancer |
Subtitle of host publication | A Case-Based Approach |
Publisher | Springer International Publishing |
Pages | 25-35 |
Number of pages | 11 |
ISBN (Electronic) | 9783031371356 |
ISBN (Print) | 9783031371349 |
DOIs | |
State | Published - Jan 1 2023 |
Keywords
- Bethesda III
- Bethesda IV
- Indeterminate Thyroid FNA Cytology
- Molecular testing
- Thyroid nodule
ASJC Scopus subject areas
- General Medicine